{"disease":{"id":"bone-cancer-metastatic","name":"bone cancer metastatic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06805812","title":"Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT06430411","title":"Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT07030569","title":"RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT04170634","title":"Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study","phase":"","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06859801","title":"A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Society of Interventional Oncology","has_results":false},{"nct_id":"NCT06532799","title":"TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT02715856","title":"Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases","phase":"NA","overall_status":"TERMINATED","enrollment_count":70,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT06972628","title":"Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Ebrahim S Delpassand","has_results":false},{"nct_id":"NCT05241132","title":"Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":27,"lead_sponsor_name":"Wei Xu","has_results":false},{"nct_id":"NCT07043608","title":"Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Kelly Fitzgerald, MD","has_results":false},{"nct_id":"NCT06008483","title":"A Dose Finding Study to Treat Bone Tumor(s)","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":17,"lead_sponsor_name":"QSAM Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06716294","title":"Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation","phase":"","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"National and Kapodistrian University of Athens","has_results":false},{"nct_id":"NCT03525392","title":"Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Ipsen","has_results":true}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}